RUNX1 and acute myeloid leukemia: EVI1High cells cultured in biomimetic 3D collagen scaffolds develop resistance to ara-C but not to HDACis, suggesting that cell-extrinsic mechanisms of acquired resistance to chemotherapy agents can be overcome by targeting EVI1 in 3q26 AML (Supplementary Fig. 4J).